The view from the chair
Seven years ago, Chancellor Mark S. Wrighton (left) asked Andrew C. Taylor, executive chairman of Enterprise Holdings and a life trustee of the university, to chair the public phase of Leading Together.
Taylor Institute develops mice available from JAX Labs.
Also Known As: δ* KI δ* KI is a CRISPR/cas9-made knock-in allele with a T269Y mutation in Gabrd exon 8 that renders δ-containing receptor populations insensitive to picrotoxin (PTX). These mice allow chemogenetic isolation of δ-containing GABAA receptors, and may be useful for neurological studies of receptor, ion channel and synapse biology, neurotransmitters, and glutamate/GABA transmission.
Alcohol dependence, psychiatric disorders share genetic links
Key alcoholism gene influences how quickly body metabolizes alcohol
MRI scans shows promise in predicting dementia
Brain changes evident in scans before memory, cognitive decline
Taylors Provide $10 Million to Accelerate Psychiatric Drug Development
In 2012, Andrew and Barbara Taylor and the Crawford Taylor Foundation pledged $20 million to the Department of Psychiatry at Washington University’s School of Medicine to establish a research institute dedicated to advancing new treatments for mental illnesses. Just six years later, investigators in the department’s Taylor Family Institute for Innovative Psychiatric Research are on […]
Taylor family establishes $10 million scholarship challenge
A $10 million commitment from Andrew Taylor, a life trustee at Washington University in St. Louis, and his wife, Barbara, will establish the Taylor Family Scholarship Challenge, which will match all new and increased gifts for undergraduate scholarships received by the conclusion of Leading Together: The Campaign for Washington University on June 30, 2018, as well as […]
$3 million to help expand Wolfram syndrome research
Grant to renew annual clinic, advance understanding of rare disorder
Depression in Young Children is Treatable
Parent-child interactive therapy decreases depressive symptoms in kids.
Depressed patients see quality of life improve with nerve stimulation
A national study led by institute affiliate Charles Conway, MD, indicates that people treated with nerve stimulation experience significant improvements in quality of life, even when their depression symptoms don’t completely dissipate.
New approach to developing antidepressants
In the new research, Steve Mennerick, Institute scientific director, and his colleagues focused on GABA receptors located on neurons in the brain’s hippocampus, a part of the brain involved in learning and memory. Using CRISPR, they mutated the delta-type GABA receptors to isolate and test their role in brain functioning.
Cicero receives Pioneer Award
Theodore J. Cicero, PhD, the John P. Feighner Professor of Psychiatry at Washington University School of Medicine in St. Louis, is the 2018 recipient of the Pioneer Award from the National Council on Alcoholism and Drug Abuse (NCADA).
We welcome Meaghan Creed and Lex Kravitz to the WashU Community!
We are so excited to have Meaghan Creed and Lex Kravitz headed to St. Louis to join the Washington University School of Medicine research community.